BRM Immunotherapy of Orthotopically Implanted Murine Bladder Tumours: Treatment Response by Monitoring MRI
The authors evaluated magnetic resonance imaging (MRI) for monitoring orthotopic bladder tumour growth and treatment response to intravesical immunotherapy with the biological response modifiers (BRMs): recombinant tumour necrosis factor alpha (TNF-α), combination of TNF-α plus interferon gamma (IFN...
Saved in:
Main Authors: | Salam A Kadhim, Joseph L Chin, Bertha M Garcia, Peeyush K Lala, Chris J Norley, Barbara A McLean, Stephen J Karlik |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1992-01-01
|
Series: | Canadian Journal of Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/1992/510914 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression of SMADs in orthotopic human endometrium, ovarian endometriosis, and endometriotic lesions in a murine model
by: Yuri Kadota, et al.
Published: (2024-04-01) -
Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
by: Beatriz Ramos, et al.
Published: (2025-02-01) -
AM3, an Oral BRM: Protective Agent against Iatrogenic Bone-Marrow and Liver Damage in Breast Cancer Patients under Conventional Adjuvant Radiochemotherapy
by: Vicente G Villarrubia, et al.
Published: (1992-01-01) -
Neoantigen immunotherapy: a novel treatment for bladder cancer
by: Ruiyang Lv, et al.
Published: (2025-01-01) -
Response of Immunotherapy to Tumour-TICLs Interactions: A Travelling Wave Analysis
by: Joseph Malinzi, et al.
Published: (2014-01-01)